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Abstract: The capacity to load bacteriophages into electrospun nanofibers of two representative
biocompatible polymers has been evaluated, paying special attention to the possibility of preserving
their antibacterial activity. Specifically, the work involves the following steps: (a) Evaluation of
the effect of the applied electrical field on the phage activity; (b) evaluation of the activity when
a lyophilization process could be avoided by using water soluble polymers (e.g., poly(ethylene
glycol); (c) evaluation of the activity when dissolution of the polymer requires an organic solvent
and lyophilization is theoretically necessary. In this case, a poly(ester urea) (PEU) derived from
the natural L-leucine amino acid has been considered. Adsorption of commercial bacteriophage
preparations into calcium carbonate particles was demonstrated to be a promising methodology to
avoid lyophilization and keep the initial bactericide activity at a maximum. Phagestaph and Fersis
bacteriophage commercial preparations have been selected for this study due to their specific activity
against Staphylococci (e.g., S. aureus) and Streptococci (e.g., S. pyogenes) bacteria. Adhesion and
proliferation assays using epithelial cells demonstrated the biocompatibility of both unloaded and
bacteriophage-loaded PEU scaffolds, although some slight differences were observed depending on
the type of bacteriophage and the selected preparation methodology.
Keywords: bacteriophages; electrospinning; scaffolds; poly(ester urea)s; bactericides; biocompatibility
1. Introduction
Phage therapy is the application of a bacteria-specific virus to treat pathogenic bacterial infections.
This therapy has many potential applications in human medicine as well as veterinary science,
agriculture, and food processing. The discovery of bacteriophages is controversial since different claims
have been formulated [1–3]. Nevertheless, it is recognized that d’Herelle performed the pioneering
work and proposed the name of bacteriophages for viruses capable of invading bacterial cells and
disrupting bacterial metabolism, causing bacterial lysis. Basically, bacteriophages undergo a lytic cycle
through which they self-replicate and lyse a broad variety of bacterial strains.
Specifically, bacteriophages appear highly interesting as a relatively cost-effective antibiotic
alternative to treat bacterial infections that have developed antibiotic resistance. Bacteriophages also
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appear highly interesting when biofilms resistant to antibiotic penetration (e.g., those covered by
a polysaccharide layer) were produced. The high specificity of bacteriophages toward both Gram-positive
and Gram-negative bacteria is also attractive since they are seen to be harmless to the host organism as
well as to beneficial bacteria (e.g., gastrointestinal flora). Nowadays, bacteriophages have been revealed
to be highly appropriate for the treatment of poorly-healing wounds, e.g., in diabetic and bedridden
patients as well as those affected by venous stasis ulcers [4,5]. The treatment has greater costs since
liquid preparations of phages are applied locally, requiring a frequent change of dressings. Therefore,
recent approaches deal with the incorporation/encapsulation of phages into a polymeric matrix or their
immobilization onto a polymeric surface.
Biodegradable poly(ester amide)s based on amino acids have been employed as matrices for the
deposition of a combination of phages with other medicaments. The product has been commercialized
under the trademark of PhagoBioDerm, being beneficial for the treatment of chronic wounds [6] and
multidrug-resistant Staphylococcus aureus infections [7]. Bacteriophages have also been revealed to
be effective in the treatment of Pseudomonas aeruginosa [8–11], which is probably the microorganism
responsible for the most common infections in hospital environments [12]. These infections tend
toward chronicity, with a mortality rate of up to 61%, since infections cannot be effectively treated with
any antibiotic combination [13]. Escherichia coli is also a common multidrug-resistant Gram-negative
bacterium that is able to spread, rapidly causing sepsis with a high mortality rate [14]. The infection of
E. coli by the bacteriophage T4 is highly effective and has been one of the most studied model systems
in microbiology [14,15]. Encapsulation of phages in microspheres by means of an emulsion-solvent
extraction method has also been performed, but results showed a loss of activity that was attributed to
the organic solvent employed [16]. Creation of antimicrobial surfaces by passive immobilization [17],
through chemical bioconjugation [18], covalent anchoring [19], or by electrostatic interactions, taking
advantage of the different charge distribution between head and tail [20], has also been assayed, with
differing levels of success. Logically covalent attachment was revealed to be more effective than simple
electrostatic binding since bacteriophage detachment could be decreased [21]. Though PhagoBioDerm
showed remarkable wound healing potential, it represents a film material (“artificial skin”) that is
rather rough and irritating to wounds, especially for large wounds and burns; to allow the wound
exudate to freely come out and the wound surface to breathe, the PhagoBioDerm film is perforated
using special equipment. Therefore, it is desirable to produce soft and nonwoven porous wound
dressings, which can provide both free exudate evacuation and wound breathing. Such materials can
be obtained via the electrospinning technique.
Electrospinning is currently an easy process to create micro/nanofibers and mats with a tunable
porosity after the accumulation of fibers. An additional advantage of the technique is the great versatility
that allows for working with a great variability of polymeric materials and loading different active agents
for the required application (e.g., the preparation of scaffolds with bactericidal properties). Basically,
a high electrical field is applied to a liquid droplet held at the end of a capillary tube. The drop becomes
electrically charged and stretched when the electrostatic repulsion counteracts the surface tension. In this
way, a jet is ejected towards a grounded target (collector) [22–24]. Solution characteristics (e.g., solvent,
polymer concentration, conductivity, vapor diffusivity) and operational parameters (e.g., distance
between the needle to the collector, flow rate, and applied voltage) can easily be modified in order to get
continuous and homogeneous fibers with the desired morphology. Great efforts are nowadays focused
on overcoming one of the main limitations of the technique: its scalability for industrial production.
Many technological solutions have already been proposed to allow large-scale production as reviewed
by Persano and collaborators [25].
Electrospun scaffolds have good characteristics of wound dressings: porosity, permeability,
flexibility, and the ability to deliver antimicrobial agents through the selection of the appropriate
polymer matrix [26].
Scarce works have focused on the encapsulation of phages by the electrospinning technique.
In this way, water-soluble polymers like polyvinyl pyrrolidone (PVP) [27,28], polyvinyl alcohol
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(PVA) [29], and poly(ethylene oxide)/cellulose diacetate [30,31] have been assayed for M13, T4, T7,
and λ bacteriophages, with results not being completely satisfactory due to a significant loss of
activity that was attributed to phage dehydration and solvent evaporation during the electrospinning
process. The addition of excipients such as sodium chloride, magnesium sulfate, or sucrose was
reported to avoid the damaging effect of dehydration and maintain a high level of bacteriophage
infectivity after electrospinning. In fact, these excipients were able to provide protection over storage
and mitigate environmental effects on the dried samples [32]. Bacteriophage T4 has also been
effectively incorporated into poly(ε-caprolactone)/collagen (30%/70% w/w) electrospun fibers to
eradicate E. coli infections (i.e., the inhibition efficiency of E. coli activity around 90%) while establishing
hemostasis [15]. An organic 1,1,1,3,3,3-hexafluoroisopropal solution was employed in this case to
perform the electrospinning process. Emulsion and coaxial electrospinning processes have also been
considered in order to overcome the problems associated with the sensitivity of bacteriophages.
In this way, good results were achieved by allocating bacteriophages into the core of a core/shell
fiber protective structure [30]. Finally, it should be pointed out efforts focused on immobilizing
bacteriophages onto the surface of electrospun scaffolds. Thus the vB_Pae_Kakheti25 bacteriophage,
which is highly effective against P. aeruginosa, was covalently immobilized through the formation of
amide linkages onto PCL electrospun nanofibers. Materials with immediate and complete bacterial
reduction were reported [8].
In order to evaluate the possibility of encapsulating bacteriophages into scaffolds constituted of
electrospun nanofibers, we have considered it necessary to structure the present work in three different
steps: (a) Evaluation of the effect of electric field on the activity of bacteriophages, (b) evaluation of
the bactericide activity from electrospun scaffolds prepared using an aqueous media and avoiding
a pre-lyophilization step, and (c) evaluation of the viability of bacteriophages when the electrospun
fiber matrix consists on a water-insoluble polymer. This matrix can avoid the prompt phage delivery
that is expected when the scaffold becomes in contact with an aqueous medium capable of solubilizing
the polymer.
We have selected a leucine-based poly(ester urea) (PEU) (Figure 1) since α-amino acid-based
polymers are receiving great attention as new biodegradable materials for biomedical applications
due to their favorable combination of properties [33,34]. High-molecular-weight PEUs with desirable
material properties are being used, for example, as implantable surgical devices and can be easily
synthesized via interfacial polycondensation [35]. Specifically, a derivative of L-leucine, carbonic acid,
and 1,6-hexanediol (named PEU 1L6) has been selected. The polymer is characterized by a melting
temperature of 114 ◦C, a glass transition temperature of 47 ◦C, and a tensile strength at yield, elongation
at break, and Young’s modulus of 21 MPa, 114%, and 622 MPa, respectively. Previous works indicated
that the polymer could be electrospun into micro/nanofibers loaded with antibacterial drugs [36].
Furthermore, hybrid electrospun scaffolds constituted of a mixture poly(3-thiophene methyl acetate)
and a copolymer based on 1L6 showed promising conductive and biodegradable properties [37].Fibers 2018, 6, x FOR PEER REVIEW  4 of 20 
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2. Materials and Methods
2.1. Materials
All chemicals were of ACS grade and used without further purification. The selected PEU was prepared
by interfacial polymerization, as previously described (Figure S1) [36]. Specifically, di-p-toluenesulfonic
acid salt of bis-L-leucinehexane-1,6-diester (L6) was reacted with triphosgene. The average molecular
weight and polydispersity index were 70,000 g/mol and 1.4, respectively. Figures S2–S6 report basic
characterization and enzymatic degradation data concerning 1L6 films and electrospun scaffolds [35].
Poly(ethylene glycol) (PEG) with an average molecular weight of 35,000 g/mol, was purchased from
Sigma-Aldrich. Pharmaceutical-grade calcium carbonate (mean particle size 6.20± 0.013 µm) was kindly
provided by JSC Biochimpharm, Tbilisi, Georgia. The particles’ size was assessed in a water suspension
using laser particle size analyzer LS-C(III) (OMEC Instruments Co., Ltd., Zhuhai, China).
Fersis bacteriophage is a sterile filtrate of phage lysates of Staphylococci (S. aureus and S. epidermidis)
and Streptococci (S. pyogenes, S. sanguis, S. salivarius and S. agalactiae), being commercially employed in
therapeutic and prophylactic purposes in pyo-inflammatory and enteric infections caused by the above
mentioned microorganisms. Fersis bacteriophages have a typical morphology with well-defined capsid
and tail parts (Figure 2a). The preparation was provided by the G. Eliava Institute of Bacteriophages,
Microbiology and Virology of Georgia.
Phagestaph consists of a cocktail of bacteriophages that exhibit different morphologies, as shown
in Figure 2b–f. The product is also commercially available and has been designed with specific action
against Staphylococcus aureus. Phagestaph bacteriophages were purchased from JSC Biochimpharm,
Tbilisi, Georgia.
Adsorption of phage on calcium carbonate particles was done according to [24]. Typically, 300 mL
of liquid bacteriophage were added to 30 g of powdered CaCO3 at room temperature (i.e., a 1:10 w/v
dispersion was obtained). The mixture was thoroughly homogenized by stirring for 20 min. The mixture
was subsequently kept at room temperature for an additional 30 min without agitation. The precipitated
solid was filtered off and dried in a vacuum at 40–45 ◦C over a water-adsorbent substance (anhydrous
Na2SO4 or silica gel). After such treatment, a significant portion of the water-soluble salts and organic
admixtures of the initial phage solution was removed [38].
The microbial culture was prepared with reagents and labware from Scharlab (Spain). Staphylococcus aureus
(S. aureus) ATCC 25923 (American Type Culture Collection, Manassas, VA, USA) Epithelial-like (Vero) cells
(ATCC, Manassas, VA, USA) were used in this work for cell adhesion and proliferation studies.Fibers 2018, 6, x FOR PEER REVIEW  5 of 20 
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(b), Siphoviridae (c), Podoviridae (d) and Leviviridae (e,f) bacteriophages that form part of the Phagestaph
commercial reparation.
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2.2. Measurements
Molecular weight was estimated by gel permeation chromatography (GPC) using a liquid
chromatograph (Shimadzu, model LC-20AD, Kyoto, Japan) equipped with a LC solution GPC software
(Shimadzu). The number and weight average molecular weights and molar-mass dispersities were
calculated using poly(methyl methacrylate) standards.
Contact angles (CA) were determined at room temperature with sessile drops using an OCA-15
plus Contact Angle Microscope (Data-Physics Instruments GmbH, Filderstadt, Germany) and SCA20
software. Contact angle values of the right and left sides of distilled water drops were measured and
averaged. Measurements were performed 10 s after the drop (0.5 µL) was deposited on the sample
surface. All CA data were an average of six measurements on different surface locations.
A Philips TECNAI 10 electron microscope was used and operated at 100 kV for observation of the
morphology of bacteriophages. A Shimadzu 3600 spectrometer was employed for absorbance measurements.
2.3. Electrospinning
Electrospun fibers were collected on a target placed at different distances (10–25 cm) from the needle
tip (inside diameter of 0.84 mm). The voltage was varied between 10 and 30 kV and applied to the target
using a high-voltage supply (Gamma High Voltage Research, ES30-5W). Polymer solutions were delivered
via a KDS100 infusion syringe pump (KD Scientific, Holliston, MA, USA) to control the mass-flow rate
(from 0.5 to 5 mL·h−1). All electrospinning experiments were carried out at room temperature. Electrospun
fiber scaffolds were prepared using optimized parameters (i.e., needle tip–collector distance, voltage and
flow rate) and solvent conditions (i.e., solvent ratio and polymer concentrations).
Electrospinning of PEG was carried out using the commercial Phagestaph solution (F), a 1:1 dilution
of Phagestaph with water (WF) and water alone (W).
Electrospinning of PEU was performed in an chloroform:ethanol (10:1 v/v) mixture. Bacteriohages
were incorporated by addition of the lyophilizate of the provided Phagestaph or Fersis preparations.
Alternatively, calcium carbonate particles with bacteriophages adsorbed on their surface were added
to the electrospinning solution. In this case, salts and organic residues of the initial solution could
be avoided.
2.4. Morphology of Electrospun Scaffolds
Optical microscopy studies were performed with a Zeiss Axioskop 40 microscope. Micrographs were
taken with a Zeiss AxiosCam MRC5 digital camera. Detailed inspection of texture and morphology of
electrospun samples was conducted by scanning electron microscopy using a Focus Ion Beam Zeiss Neon
40 instrument (Carl Zeiss, Oberkochen, Germany). Carbon coating was accomplished using a Mitec K950
Sputter Coater fitted with a film thickness monitor k150×. Samples were visualized at an accelerating
voltage of 5 kV. Diameters of electrospun fibers were measured with the SmartTiff software from Carl Zeiss
SMT Ltd., Oberkochen, Germany.
2.5. Bacterial Growth
S. aureus bacterium was selected to evaluate the antimicrobial effect of electrospun 1L6 scaffolds loaded
with the selected bacteriophages. The bacteria were previously aerobically grown to exponential phase in
broth culture (brain heart infusion medium, BHI). Growth experiments were performed in polystyrene
tubes using 5 mL of broth. Square pieces (10 mm× 10 mm) of the electrospun scaffold with a thickness of
0.1 mm were place into each tube. Then, 1 mL of broth culture containing 103 culture forming units (CFU)
was seeded on the electrospun fiber mats. The cultures were incubated at 37 ◦C and agitated at 200 rpm.
Aliquots of 100 µL were taken at predetermined time intervals for absorbance measurement at 650 nm
in a plate reader. Thus, turbidity was directly related to bacterial growth. All assays were conducted in
triplicate and the values averaged.
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2.6. Virus Plaque Assay
Bacteriophages were quantified by means of the double agar method, which allowed for determining
circular zones of bacterial lysis (named plaque) caused by the phage action. To this end, a small volume
of a dilution of phage suspension (100 µL) and host cells (200 µL of a bacterial culture with A600 = 0.3)
were mixed for 20–30 min at 37 ◦C and 80 rpm. Then, 3 mL of BHI soft agar (7% agar) was added, mixed
in molten state, and subsequently poured onto an appropriate BHI agar medium (15% agar). A thin layer
was formed and let to harden in order to immobilize bacteria (i.e., the virus could only infect contiguous
cells). The uninfected bacteria multiplied during incubation to form a confluent lawn of bacterial growth
over the surface of the plate. Each infected bacterium burst after a short time and liberated progeny
bacteriophages that infect adjacent bacteria, which in turn were lysed. This chain reaction spread in
a cycled motion until led to a halt by a decline in bacterial metabolism. Phage activity was evaluated by
counting plaques (i.e., halts) and quantified as plaque-forming units per mL (PFU/mL).
2.7. Cell Adhesion and Proliferation Assays
Adhesion and proliferation tests were performed as a measure of the biocompatibility of the 1L6
scaffolds loaded with bacteriophages. Vero cells were cultured in Dulbecco’s modified Eagle medium
(DMEM), as previously reported [39]. Unloaded and bacteriophage-loaded PEU 1L6 scaffolds (pieces of
1 cm × 1 cm) were placed into the wells of a 24-well culture plate. Samples were fixed in the wells with
a small drop of silicone (Silbione® MED ADH 4300 RTV, Bluestar Silicones France SAS, Lyon, France) and
then sterilized by UV-radiation in a laminar flux cabinet for 15 min. For the cell adhesion assay, aliquots of
50–100 µL containing 5 × 104 cells were seeded onto the electrospun samples in each well and incubated
for 24 h for adhesion assay, while 2 × 104 cells were cultured by 72 h for the proliferation assay.
The cellular viability was evaluated by the standard method of MTT using five replicates and the
results were averaged. Samples with adhered and grown cells on the mats were fixed with 2.5% w/v of
glutaraldehyde at 4 ◦C overnight. They were subsequently dehydrated and processed for observation
by scanning electronic microscopy.
2.8. Statistical Analysis
Values were averaged and graphically represented, together with their respective standard
deviations. Statistical analysis was performed by one-way ANOVA test to compare the means of all
groups, and then Tukey’s test was applied to determine a statistically significant difference between
the two groups. The test confidence level was set at 95% (p < 0.05).
3. Results
3.1. Effect of the Electrical Field on the Morphology and Activity of Bacteriophages
It has been evaluated the value of the electrical potential, V, along the cylindrical geometry of the
electrospinning process using a homemade program and considering a constant dielectric permittivity,
ε, and a null value for the charge density ρv. Namely, the effect derived from the small amount of
solvent in the process was considered negligible. Under these approximations, the typical Poisson
equation (Equation (1)) that defines the electrical potential generated by regions with a fixed potential
becomes the Laplace equation (Equations (2) and (3) when the divergence operator, ∇, is expressed in
cylindrical coordinates). The relation between the electric potential and the electric field, E, is defined
by Equations (4) and (5).
∇2V = −ρV/ε (1)
∇2V = 0 (2)
∂2V
∂ρ2
+
1
ρ
∂V
∂ρ
+
1
ρ2
∂2V
∂x∅2 +
∂2V
∂z2
= 0 (3)
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E = −∇V (4)
E = −∂V
∂ρ
ρˆ− 1
ρ
∂V
∂∅∅ˆ−
∂V
∂z
zˆ (5)
where ρ, ϕ, and z indicate the radial, azimuthal, and axial directions, respectively.
The problem can be simplified to two dimensions considering the azimuthal symmetry of the
process. Resolution of the bidimensional equation requires an iterative process since the integration
region requires to be defined by fixed conditions, which a priori are only known for the planar collector
surface and the needle tip. The iterative successive over-relaxation (SOR) method was applied to solve
Equation (3) and specifically Figure 3 and Figure S7 show the equipotential lines and the modulus of
the electrical field that were determined for an applied voltage of 30 kV. The maximum value of the
electrical field was logically found at the needle tip and corresponded to a value of 40 kV·cm−1.
In order to evaluate the effect of the field on the activity of bacteriophages we centered the attention
on the time that the electrospun solution was located close to the needle due to the non-homogeneous
shape of the electrical field, The ratio between the volume of the Taylor cone and the flow rate, ϕ,
allows estimating the time, pie, at which the solution was under the maximum electrical field:
τe =
pi
3
× R2con ×
hcon
∅ (6)
where Rcon and hcon are the radius (equivalent to the radius of the needle) and the height of the
cone, respectively.Fibers 2018, 6, x FOR PEER REVIEW  8 of 20 
 
Figure 3. Calculated equipotential lines for a potential of 30 kV. 
The equation indicates that πe becomes 5 min for the minimum assayed flow rate of 0.1 mL/h 
and an overestimated cone height of 3.2 cm. 
In order to see the effect of the electric field on the phage activity, the commercial Phagestaph 
preparation was deposited without any previous treatment (e.g., dilution or lyophilization) in a 
parallel plane capacitor. The maximum electric field at which bacteriophages should be exposed 
during electrospinning (i.e., 40 kV/cm) was applied for πe values of 0.1 and 5 min. The bacteriophage 
activity was evaluated by the double agar method (Figure 4) and compared with the activity 
attained with the commercial preparation. The studies were performed in triplicate and showed that 
the activity was not modified by the effect of the field. Specifically, values of 5.0 × 103 ± 0.8 × 103 
PFU/mL, 6.5 × 103 ± 0.5 × 103 PFU/mL and 5.5 × 103 ± 0.6 × 103 FPU/mL were determined for the 
control and after exposition for 0.1 min and 5 min, respectively. Transmission electron micrographs 
showed also that morphology remained unaltered, being well defined capsids with diameters 
around 60–100 nm clearly detected as well as ca. 250 nm long tails in the case of Myoviridae and 
Siphoviridae species (Figure S8). 
 
Figure 4. Overlayer agar plate of a preparation of Fersis and enlargement. 
3.2. Electrospinning of PEG Loaded with Bacteriophages 
Electrospinning of PEG samples was initially performed using water (W) as solvent and high 
polymer concentration due to the low molecular weight of the polymer. A series of experiments at 
concentrations of 37%, 47%, 50% and 53 wt % were carried out, being representative electrospun 
fibers attained under typical conditions shown in Figure 5. 
Figure 3. Calculated equipotential lines for a potential of 30 kV.
The equation indicates that pie becomes 5 min for the minimum assayed flow rate of 0.1 mL/h
and an overestimated cone height of 3.2 cm.
In order to see the effect of the electric field on the phage activity, the commercial Phagestaph preparation
was deposited without any previous treatment (e.g., dilution or lyophilization) in a parallel plane capacitor.
The maximum electric field at which bacteriophages should be exposed during electrospinning (i.e., 40 kV/cm)
was applied for pie values of 0.1 and 5 min. The bacteriophage activity was evaluated by the double agar
method (Figure 4) and compared with the activity attained with the commercial preparation. The studies were
performed in triplicate and showed that the activity was not modified by the effect of the field. Specifically,
values of 5.0× 103 ± 0.8× 103 PFU/mL, 6.5× 103 ± 0.5× 103 PFU/mL and 5.5× 103 ± 0.6× 103 FPU/mL
were determined for the control and after exposition for 0.1 min and 5 min, respectively. Transmission electron
micrographs showed also that morphology remained unaltered, being well defined capsids with diameters
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around 60–100 nm clearly detected as well as ca. 250 nm long tails in the case of Myoviridae and Siphoviridae
species (Figure S8).
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3.2. Electrospinning of PEG Loaded with Bacteriophages
Electrospinning of PEG samples was initially performed using water (W) as solvent and high
polymer concentration due to the low molecular weight of the polymer. A series of experiments at
concentrations of 37%, 47%, 50% and 53 wt % were carried out, being representative electrospun fibers
attained under typical conditions shown in Figure 5.Fibers 2018, 6, x FOR PEER REVIEW  9 of 20 
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The concentration of 50 wt % was selected for further experiments since it was found to be the
minimum necessary to get continuous fibers and avoid the formation of droplets. Two different media
were selected in order to perform the electrospinning of PEG loaded with Phagestaph: the direct
commercial Phagestaph preparation (F) and its dilution with 50 v % of water (WF).
The viscosity and surface tension of the F, WF, and W media were similar (i.e., differences were
lower than 1%) but great changes were logically detected on their electrical conductivity and salt
content. Thus, conductivities of 20, 213, and 374 mS/cm were determined for W, WF, and F solutions,
respectively, whereas the content of salts was 0, 0.1, and 0.2 ppt (‰).
For the optimization of the electrospinning process the applied voltage, the flow rate and the needle
collector distance were varied between 20–30 kV, 0.1–5 mL/h and 8–15 cm, respectively. We selected the
maximum flow rate, minimum voltage, and maximum distance that allowed for forming a Taylor cone
and get homogeneous and continuous fibers, while the formation of beads and droplets was avoided.
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Basically, selected conditions tried to minimize the electric field at which bacteriophages were exposed and
the time required to get a homogeneous scaffold. Table 1 summarizes the optimal conditions determined
for each solution. The most significant variation concerns the flow rate, which became minimal when the
more conductive F solution was employed (i.e., 0.1 mL/h with respect to the 5 mL/h that was necessary
for the aqueous solution). The time, pie, at which bacteriophages were exposed to the maximum electric
field also increased with the conductivity of the solution. A needle-collector distance of 12 cm allowed
us to guarantee the complete evaporation of water and was selected for all systems since it allowed for
fibers with diameters in the appropriate range (i.e., between 620 and 818 nm). In other words, it was not
considered necessary to increase the distance for the W medium in order to compensate for the effect of
its lower conductivity.
Table 1. Optimal parameters and derived fiber morphologies for the electrospinning of PEG in the
three studied media.
Medium Voltage (kV) Flow Rate(mL/h) Distance (cm) pie
1 (s)
Diameter
(nm)
Deviation
(nm)
W 20 5 12 0.5 818 324
WF 25 0.5 12 2 652 260
F 20 0.1 12 25 620 247
1 Exposure time to the maximum electric field as determined from Equation (6).
Analysis of fiber morphology from SEM micrographs demonstrated that the diameter of the fibers
decreased as the conductivity of the solution increased (Figure 6), an effect that has extensively been
reported [40]. Specifically mean diameters of 620, 652, and 818 nm (Table 1, inset of Figure 6) were
determined for fibers coming from F, FW, and W solutions, respectively. Micrographs also revealed
that the dispersion of diameter sizes decreased with solution conductivity.
Probably the main difference between electrospun fibers is their length, since those directly
prepared from the Phagestaph solution had a length lower than 20 µm (Figure 6a), while a continuous
morphology was obtained from water (Figure 6b). The presence of microparticles and a small fiber
diameter are two factors that should be considered in order to justify the observed fiber breakage when
a highly conductive solution is used. This problem cannot obviously be related to a typical capillary
effect caused by a viscosity decrease. The Phagestaph solution contains a significant ratio of relatively
large particles (the rest of bacterial lysates) that could favor breakage when the diameter of the fiber is
smaller than a limiting value, as shown in Figure 6c.
A non-homogeneous dispersion of bacteriophages inside the electrospun fibers was revealed by TEM
images. Figure 7a corresponds to the samples prepared from the WF intermediate solution, with a preferential
location of bacteriophages being observed near the fiber surface and even a perpendicular orientation with
respect to it. This feature is a consequence of the electrostatic interactions that were established between
the positively charged polymer surface and the capsid of the phage with a preferential negative charge.
Results are consistent with the well-known trend of bacteriophages to adhere on positive surfaces [11].
Figure 7b indicates the movement and orientation of bacteriophages during the drying process.
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Evaluation of bacteriophage activity by the double agar method showed a slight decrease with respect to the
values obtained from the Phagestaph commercial sample used as the control (5.0× 103 ± 0.8× 103 PFU/mL).
Thus, values of 4.2× 102 ± 0.8× 102 PFU/mL and 3.7× 102 ± 0.6× 102 PFU/mL were determined for the
fibers processed from F and WF solutions. The most remarkable point is the fact that activity seemed not to be
affected by the electrospinning process, as seen in the results obtained in the previous section. The observed
activity decrease seems to be a consequence of the increase of viscosity in the agar plate produced by solubilization
of PEG (i.e., the mobility of bacteriophages decreased as well as the capacity to attack bacteria, as also verified
using non-electrospun samples). The lower activity of the scaffold coming from the WF solution also reflects
the lower load of bacteriophages inside the fibers since the initial F solution was diluted with the same volume
of water.
Literature data concerning the bacteriophage activity after performing an electrospinning process
from an aqueous medium are relatively scarce, with some contradictory results also having been
reported. Thus, it has been indicated that the main loss of infectivity can be related to the subsequent
storage process rather than exposure to high voltage [27]. Bacteriophages T7 and T4 were reported
to survive the electrospinning process performed from an aqueous solution of poly(vinyl alcohol)
and under an electrostatic field of 1 kV/cm. The bacteriophage activity remained at fairly high levels,
as reported in earlier work [29]. An intact viral structure and infecting ability of M13 bacteriophages
was also observed when electrospinning was performed using a highly water-soluble polymer,
PVP [28]. However, in this case the low viscosity and high surface tension of the aqueous suspensions
tended to form droplets [28].
Nevertheless, problems related to the bacteriophage dehydration caused by the rapid evaporation
of water during the single-nozzle electrospinning process have also been mentioned. Thus, negative
results have been reported using a single electrospinning process based on an aqueous solution
of poly(ethylene oxide), a result that contrasts with our observations. In this case, a large drop in
bacteriophage activity from 108 to 103 PFU·mL−1 was seen [30].
3.3. Electrospinning of PEU 1L6 Loaded with Bacteriophages
The electrospinning of both the 1L6 homopolymer and a copolymer mainly constituted by 1L6
units has recently successfully been performed using a chloroform–ethanol (10:1 v/v) solution and
a polymer w/v concentration between 10% [36] and 16% [35]. Although ethanol could affect the activity
of bacteriophages, the low ratio that has been employed for the electrospinning process could preserve
their activity, as will then be demonstrated. Optimal processing parameters corresponded to a voltage of
20–25 kV, a flow rate of 1.5–3.5 mL/h, and a tip–collector distance of 24.6 cm. Under these conditions
continuous and homogeneous fibers with an average diameter of 2.6–2.70 µm were obtained. Therefore,
the same solvent and polymer concentration were employed for the preparation of bacteriophage-loaded
PEU 1L6 scaffolds. Previous experiments performed with solutions containing bactericide agents and
enzymes, even at very low concentrations, demonstrated a high influence on the fiber morphology or
even on the optimal electrospinning parameters (i.e., the diameter decreased to 1.29 µm and 0.46 µm when
α-chymotrypsin and the cationic poly(hexamethylene)biguanide were loaded, respectively). In addition,
a flow rate of 0.5 mL/h was required when the enzyme was employed.
Freeze-dried bacteriophages were suspended in the chloroform–ethanol (10:1 v/v) solution
of 1L6 at a concentration of 10% (w/v). The presence of bacteriophages in the electrospinning
solution forced us to again test the optimal processing conditions, starting, however, from the above
indicated parameters. A common collector distance of 24.5 cm and a voltage of 30 kV were found
to be appropriate for different samples but relatively large variations in the flow rate were required
depending on the type of bacteriophage loaded. Specifically, 1.5, 1.0, and 0.8 mL/h were necessary
for unloaded and Phagestaph- and Fersis-loaded samples, respectively. Note that these conditions
are clearly different from those determined from PEG, as expected from the different properties of
polymers and of the electrospun medium (i.e., a lower polarity of chloroform with respect to water led
to larger diameters and a change from a nanometric to a micrometric size).
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Figure 8 shows the SEM images of the 1L6 matrices loaded with the two commercial
bacteriophages. It can be clearly observed in the images that the fibers had smooth surfaces, circular
cross sections, and rather similar diameters that ranged in the micrometric scale. Thus, average
diameters of 1.62 ± 0.32 µm and 1.95 ± 0.45 µm were determined for scaffolds incorporating
Phagestaph and Fersis, respectively (Table 2). Both values were clearly smaller than the diameter
found for the unloaded 1L6 fibers (2.70 ± 0.11 µm), despite the highly similar operational parameters
employed for the three samples. It should be pointed out that the electrospinning solution should
contain salts and residues coming from the lyophilization of the initial bacteriophage solutions and
consequently the increase of the solution conductivity had a significant influence on the diameter.
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Figure 8. SEM micrographs showing electrospun 1L6 scaffolds loaded with: (a) Phagestaph and (b) Figure 8. SEM micrographs showing electrospun 1L6 scaffolds loaded with: (a) Phagestaph and (b) Fersis
freeze-dried preparations. Diameter distributions are shown on the right of the corresponding micrograph.
We have also optimized the conditions required for the electrospinning of calcium carbonate particles
having adsorbed bacteriophages. This process has two main advantages: A problematic lyophilization
process is avoided and the salts and bacteria residue that are typical of the commercial phage solution can
be separated and removed. The carbonate particles (2.5% (w/v)) were suspended in the above indicated
solution of 1L6 in chloroform–ethanol. The suspension was homogenized by magnetic stirring before
performing electrospinning, with only a significant increase of the flow rate up to 5–6.7 mL/h required in
order to get continuous fibers without evidence of formation of drops and/or beads. Figure 9 shows the
surface morphology of electrospun fibers prepared from the two types of bacteriophages adsorbed on
carbonate. The fibers clearly reveal the presence of round protuberances associated with aggregates of
carbonate particles, and appeared to be randomly distributed along the fibers. Furthermore, aggregates
were well encapsulated into the fibers, which exhibited a relatively smooth texture. Average diameters
were 3.45± 0.41 µm and 3.32± 0.40 µm for Phagestaph- and Fersis-loaded samples, respectively (Table 2).
A clear increase was observed with respect to samples prepared without carbonate as a logical consequence
of the increase of the flow rate (i.e., 6.7 and 5 mL/h with respect to 1 and 0.8 mL/h for Phagestaph- and
Fersis-loaded samples, respectively).
Morphology of bacteriophages recovered from the electrospinning process remained unaltered,
as shown in Figure S9 for two representative samples.
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Table 2. Electrospinning parameters and diameter sizes for the unloaded and the differently loaded
1L6 samples.
Sample Voltage (kV) Flow (mL/h) Needle-Collector Distance (cm) Diameter (µm)
1L6 30 1.5 24.5 2.70 ± 0.11
1L6-Phagestaph/CaCO3 30 6.7 24.5 3.45 ± 0.41
1L6-Phagestaph 30 1 24.5 1.62 ± 0.32
1L6-Fersisi/CaCO3 30 5 24.5 3.32 ± 0.40
1L6-Fersisi 30 0.8 24.5 1.95 ± 0.45
The surface properties of 1L6 microfiber matrices, loaded with bacteriophages or not, were studied
using contact angle measurements. A 1L6 film sample was used as a reference, with a contact angle of
93.4◦ ± 1.4◦. This angle increased drastically for electrospun scaffolds (132.8◦ ± 2.5◦) as a consequence of
the increased rugosity and the presence of air pockets [41]. Scarce variations were found when samples
were directly loaded with purified Phagestaph and Fersis bacteriophages or with carbonate particles
having adsorbed bacteriophages. Thus, contact angles were 124.2◦ ± 0.7◦ and±132.2◦ ± 1.3◦ for matrices
loaded with Phagestaph, and 133.0◦ ± 1.1◦ and 134.9◦ ± 0.5◦ for matrices loaded with Fersis (Figure 10).
No significantly greater values were observed in each group when carbonate particles were incorporated
as a consequence of the small increase in roughness and porosity caused by the greater diameter of
the fibers. It is relevant that the spreading of water drops on the scaffold surface was not observed.
This feature logically indicates hydrophobic interaction between water and the polymer matrix and
a particularly good encapsulation of the hydrophilic carbonate particles.
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Figure 10. Contact angles for 1L6 films (used as control), unloaded electrospun 1L6 scaffolds and
scaffolds loaded with Phagestaph and Fersis.
3.4. Antibacterial Assays of Electrospun 1L6 Scaffolds Loaded with Bacteriophages
The antibacterial activity of the 1L6 matrix loaded with Phagestaph and Fersis bacteriophages
was assessed by quantitative measurements of the inhibition of bacterial growth in broth. S. aureus
was selected to evaluate this antimicrobial effect (Figure 11).
Figure 11a shows the bacterial growth curves for S. aureus in contact with scaffolds loaded
with either bacteriophages from the lyophilized Phagestaph preparation or bacteriophages from the
adsorption of Phagestaph in calcium carbonate. Typical bacterial growth dynamics were found with
the control sample and the unloaded 1L6 scaffold. Thus, curves showed the initial lag phase (first 6 h),
the exponential growth or logarithmic phase (up to 30 h), and finally the stationary phase that lasts up
to 98 h.
The inhibitory effect of scaffolds loaded with Phagestaph was clearly detected after 72 h of culture.
The relative growth decreased to 30% and 42% considering the scaffolds loaded with bacteriophages
adsorbed into carbonate particles and with lyophilized bacteriophages, respectively. The inhibition was
similar, although a slightly higher effect was observed when the lyophilization process was avoided.
Thus, adsorbed bacteriophages were highly active, with no decrease detected after a slower release.
After the inhibition period, a new episode of bacterial growth took place, as can be inferred from the
change on the slope of the curve. This feature is in good agreement with the well-known cyclical
growth of bacteriophages.
Figure 11b shows the bacterial growth curves for S. aureus in contact with scaffolds loaded with
either bacteriophages from the lyophilized Fersis solution or bacteriophages from the adsorption of
Fersis on calcium carbonate. In this case the lag phase extended up to 8 h, the exponential phase up to
30 h, and the stationary phase up to 98 h. The inhibition effect was also detected after 72 h; specifically,
the relative growth decreased to 60% and 48%, with better results again obtained when non-lyophilized
samples were employed. After this period, a new episode of bacterial growth took place.
Lytic activity of the different 1L6 scaffolds loaded with bacteriophages and determined by the double
agar method is compared in Table 3. Results obtained with Fersis and Phagestaph are rather similar
and allow us to make the following general conclusions: (a) The activity of the initial phage solutions
slightly decreased when a lyophilization step was necessary (i.e., from 5× 103 to 1× 103 PFU/mL for
Phagestaph and from 4 × 103 to 3 × 103 PFU/mL for Fersis); (b) adsorption of bacteriophages onto
calcium carbonate particles did not cause a significant decrease in activity; (c) the electrospinning process
did not produce a loss of phage activity despite the use of organic solvents and the application of an
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electric field; d) scaffolds with greater activity and specifically with similar values to those attained with
the initial/commercial preparations were obtained by the incorporation of calcium carbonate particles
on which bacteriophages were previously adsorbed. All these changes were small because the exponent
value was always conserved when counting PFU.
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Figure 11. (a) Growth curves of the bacterium S. aureus in the presence of the control, the unloaded
PEU 1L6 scaffolds and those loaded with Phagestaph as indicated in the legend. (b) Growth curves
of the bacterium S. aureus in the presence of the control, the unloaded PEU 1L6 scaffolds, and those
loaded with Fersis, as indicated in the legend.
Table 3. Lytic activity of different preparations of Phagestaph and Fersis bacteriophages.
Sample Phage Activity (FPU/mL)
Phagestaph initial sample 5 × 103
Phagestaph after lyophilization 1 × 103
Phagestaph adsorbed in CaCO3 4 × 103
Electrospun fibers containing Phagestaph adsorbed in CaCO3 4 × 103
Electrospun fibers containing Phagestaph 2 × 103
Fersis initial sample
Fersis after lyophilization
Fersis adsorbed in CaCO3
4 × 103
3 × 103
4 × 103
Electrospun fibers containing Fersis adsorbed in CaCO3
Electrospun fibers containing Fersis
4 × 103
2 × 103
Positive results concerning the activity of bacteriophages after electrospinning from an organic
solvent are scarce. Probably, the most clear result was obtained with poly(ε-caprolactone)/collagen
electrospun membranes from 1,1,1,3,3,3-hexafluoroisopropanol solutions. These exhibited an optimal
antibacterial effect with an inhibition efficiency of E. coli activity above 90% [15]. In this sense, the use
of the selected poly(ester urea), a chloroform–ethanol medium and the adsorption of bacteriophages
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into CaCO3 particles appear an interesting methodology to provide new scaffolds with preserved
bacteriophage activity.
3.5. Biocompatibility of Electrospun 1L6 Scaffolds Loaded with Bacteriophages
1L6 scaffolds prepared by electrospinning had a tridimensional pore structure that turns out to
be an excellent support for the adhesion and growth of eukaryotic cells. Figure 12a shows that the
adhesion percentages for Vero cells (epithelial cells) were higher for 1L6 scaffolds than for the control
(2D surface of the culture plate). The best adhesion results were obtained for 1L6 scaffolds loaded with
Phagestaph independently of being prepared from the lyophilized commercial solution or through
calcium carbonate particles. In the case of Fersis, the adhesion results were slightly worse, but still
better than determined for the control.
Vero cells proliferated better with respect to the control on both unloaded 1L6 matrices and
those incorporating phages (Figure 12b). Phagestaph-loaded samples displayed slightly lower
proliferation than the unloaded scaffold, with no significant differences detected between the two
loading procedures. It should be pointed out that scaffolds loaded with Fersis showed higher
proliferation percentages despite the result not being so positive when the first adhesion event
was considered.
In summary, growth percentages were always significantly (p < 0.05) higher than those determined
for the control. Thus, it was possible to infer that new scaffolds were fully biocompatible and that
encapsulated bacteriophages were not cytotoxic for Vero epithelial cells.
Micrographs of cellular monolayers grown onto the scaffolds loaded with phages coming from
lyophilized Phagestaph and Fersis preparations are given in Figure 12c,d. The SEM images clearly
demonstrate that loaded bacteriophages did not cause a cytopathic effect in Vero cells. The cells’
monolayer was well formed, as shown by the intimate contact between cells, and cell spreading was
able to colonize the scaffold through its porous structure.
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4. Conclusions
Phagestaph and Fersis bacteriophages can effectively be encapsulated into electrospun nanofibers of
a poly(ester urea), retaining their initial bactericide activity. Results were supported by a previous study on
the effect of electric field on bacteriophages, which indicated the capacity of bacteriophages to survive an
electrical field as high as 40 kV·cm−1 for 5 min, which exceeds the amount of time necessary for a minimum
value of the flow rate in a typical electrospinning process. Furthermore, the viability of electrospinning to
preserve the phage activity was demonstrated using a soluble polymer (e.g., poly(ethylene glycol)) in
the initial solution of the commercial bacteriophages. In this way, the dehydration of the electrospun jet
during the drying step prior to deposition in the collector was not problematic. Finally, electrospinning
was also possible and preserved the phage activity when biodegradable polymers that required the use of
organic solvents (e.g., a chloroform/ethanol mixture) were employed. The load of bacteriophages for the
specific case of the 1L6 poly(ester urea) was accomplished according to two procedures: lyophilization of
the commercial bacteriophage solution and adsorption of bacteriophages on calcium carbonate particles.
The second method was preferable since bactericide activity similar to in the commercial solution could
be achieved while a slight loss of activity could be caused by the lyophilization process.
Supplementary Materials: The following are available online at http://www.mdpi.com/2079-6439/6/2/33/s1,
Figure S1: Synthesis scheme of poly(ester urea) 1L6, Figure S2: FTIR spectrum (a) and X-ray diffraction profile
(b) of poly(ester urea) 1L6, Figure S3: Plots of weight loss versus exposure time for 1L6 films exposed to
proteinase K (black symbol), α-chymotrypsin (garnet symbol) and lipase (blue symbol) media. Figure S4: Scanning
electron micrographs of 1L6 films after 19 days of exposure to PBS (a) and α-chymotrypsin (b) media at 37 ◦C.
Figure S5: Plots of weight loss versus exposure time for 1L6 scaffolds exposed to proteinase K (green symbols)
α-chymotrypsin (blue symbols) and lipase (red symbols) media. Figure S6: SEM micrographs of 1L6 scaffolds after
exposure to an α-chymotrypsin medium at 37 ◦C for 3 (a,d), 6 (b) and 8 (c) days. Figure S7: Calculated modulus
of the electric field for a potential of 30 kV, Figure S8: TEM micrographs showing the morphology of Myoviridae
(a), Siphoviridae (b) and Leviviridae (c) phages that form part of the Phagestaph commercial preparation after
exposition to a 40 kV/cm electric field. Scale bars 100 nm, Figure S9: TEM micrographs showing the morphology
of representative Siphoviridae (a) and Leviviridae (b) phages that were recovered from electrospun 1L6 scaffolds
directly loaded with phages (a) and with carbonate particles having adsorbed phages (b).
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